121 related articles for article (PubMed ID: 18285710)
1. Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients.
Sullivan PS; Hanson DL; Brooks JT
J Acquir Immune Defic Syndr; 2008 Jun; 48(2):163-8. PubMed ID: 18285710
[TBL] [Abstract][Full Text] [Related]
2. Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting.
Kumarasamy N; Venkatesh KK; Devaleenol B; Saghayam S; Manohar D; Poongulali S; Yepthomi T; Ambrose P; Solomon S; Mayer KH
Int J Infect Dis; 2009 Nov; 13(6):e360-4. PubMed ID: 19328734
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
4. Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.
Moyle G; Sawyer W; Law M; Amin J; Hill A
Clin Ther; 2004 Jan; 26(1):92-7. PubMed ID: 14996521
[TBL] [Abstract][Full Text] [Related]
5. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings.
Kiragga AN; Castelnuovo B; Nakanjako D; Manabe YC
J Int AIDS Soc; 2010 Nov; 13():42. PubMed ID: 21047391
[TBL] [Abstract][Full Text] [Related]
6. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
Zhou J; Jaquet A; Bissagnene E; Musick B; Wools-Kaloustian K; Maxwell N; Boulle A; Wehbe F; Masys D; Iriondo-Perez J; Hemingway-Foday J; Law M;
J Int AIDS Soc; 2012 Jan; 15(1):5. PubMed ID: 22289654
[TBL] [Abstract][Full Text] [Related]
7. Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
Gunda DW; Kilonzo SB; Mpondo BC
Pan Afr Med J; 2016; 23():26. PubMed ID: 27200131
[TBL] [Abstract][Full Text] [Related]
8. Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens.
Saetang T; Sriphrapradang C; Phuphuakrat A; Sungkanuparph S
HIV Res Clin Pract; 2020; 21(2-3):56-62. PubMed ID: 32431248
[TBL] [Abstract][Full Text] [Related]
9. Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria.
Parrish DD; Blevins M; Megazzini KM; Shepherd BE; Mohammed MY; Wester CW; Vermund SH; Aliyu MH
Int J STD AIDS; 2014 Apr; 25(5):355-9. PubMed ID: 24104694
[TBL] [Abstract][Full Text] [Related]
10. The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia.
Quiros-Roldan E; Castelli F; Lanza P; Pezzoli C; Vezzoli M; ; Biasiotto G; Zanella I
J Transl Med; 2017 Dec; 15(1):256. PubMed ID: 29258550
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients.
Saag MS; Bowers P; Leitz GJ; Levine AM;
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1037-45. PubMed ID: 15587490
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania.
Johannessen A; Naman E; Gundersen SG; Bruun JN
BMC Infect Dis; 2011 Jul; 11():190. PubMed ID: 21745396
[TBL] [Abstract][Full Text] [Related]
13. Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue.
Vrouenraets SM; Wit FW; Garcia EF; Huber M; Brinkman K; Moyle G; Domingo P; Tarr PE; Podzamczer D; Ristola M; Gatell JM; Livrozet JM; Furrer H; Reiss P;
HIV Clin Trials; 2012; 13(2):103-10. PubMed ID: 22510357
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients.
Grossman HA; Goon B; Bowers P; Leitz G;
J Acquir Immune Defic Syndr; 2003 Dec; 34(4):368-78. PubMed ID: 14615654
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.
Levine AM; Salvato P; Leitz GJ;
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):131-9. PubMed ID: 18284320
[TBL] [Abstract][Full Text] [Related]
16. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus.
Buskin SE; Sullivan PS
Transfusion; 2004 Jun; 44(6):826-32. PubMed ID: 15157246
[TBL] [Abstract][Full Text] [Related]
17. Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.
Kim AH; Jang W; Kim Y; Park YJ; Han K; Oh EJ
J Clin Lab Anal; 2013 Sep; 27(5):373-8. PubMed ID: 24038222
[TBL] [Abstract][Full Text] [Related]
18. Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.
Kowalska JD; Mocroft A; Blaxhult A; Colebunders R; van Lunzen J; Podlekareva D; Hansen AB; Machala L; Yust I; Benfield T;
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1183-8. PubMed ID: 17961102
[TBL] [Abstract][Full Text] [Related]
19. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
Curkendall SM; Richardson JT; Emons MF; Fisher AE; Everhard F
HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
[TBL] [Abstract][Full Text] [Related]
20. Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.
Gibson RM; Nickel G; Crawford M; Kyeyune F; Venner C; Nankya I; Nabulime E; Ndashimye E; Poon AFY; Salata RA; Kityo C; Mugyenyi P; Quiñones-Mateu ME; Arts EJ
Infect Dis Poverty; 2017 Dec; 6(1):163. PubMed ID: 29202874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
